Elaine Chow
About
Elaine Chow is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics.
According to data from OpenAlex, Elaine Chow has authored 187 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Endocrinology, Diabetes and Metabolism, 40 papers in Molecular Biology and 38 papers in Genetics. Recurrent topics in Elaine Chow's work include Diabetes Management and Research (48 papers), Diabetes Treatment and Management (41 papers) and Diabetes and associated disorders (32 papers). Elaine Chow is often cited by papers focused on Diabetes Management and Research (48 papers), Diabetes Treatment and Management (41 papers) and Diabetes and associated disorders (32 papers). Elaine Chow collaborates with scholars based in Hong Kong, China and United States. Elaine Chow's co-authors include A. S. Willsky, Juliana C.N. Chan, Ronald C.W., Andrea O. Y. Luk, Alice P.S. Kong, Eric S. H. Lau, Christian M. Tobias, Aimin Yang, Hongjiang Wu and Simon Heller and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
In The Last Decade
Elaine Chow
170 papers receiving 3.9k citations
Hit Papers
Peers
Elaine Chow
Josep Vehı́ Spain
Robert F. Harrison United Kingdom
Lalo Magni Italy
Ming Chen China
Naoki Tanaka Japan
Yung‐Hsiang Chen Taiwan
Hubert Roth Germany
John F. O’Brien United States
Jianmin Yang China
Philippe Moulin France
Citations per year, relative to Elaine Chow Elaine Chow (= 1×)
peers
Josep Vehı́
Countries citing papers authored by Elaine Chow
Since
Specialization
Citations
This map shows the geographic impact of Elaine Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Chow more than expected).
Fields of papers citing papers by Elaine Chow
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Elaine Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Chow. The network helps show where Elaine Chow may publish in the future.
Co-authorship network of co-authors of Elaine Chow
This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Chow. A scholar is included among the top collaborators of Elaine Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Chow. Elaine Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hua, Rong, Mai Shi, Elaine Chow, Aimin Yang, & Yin Ting Cheung. (2025). Genetic evidence for the effects of glucokinase activation on frailty‐related outcomes: A Mendelian randomisation study. Diabetes Obesity and Metabolism. 27(6). 3072–3083.
2.
Chu, Natural, Jie He, Sachin Gopalkrishna Pai, et al.. (2025). Carbohydrate Quality Is Independently Associated with Cardiometabolic Risk in Chinese Individuals with Impaired Glucose Tolerance. Nutrients. 17(7). 1123–1123.
3.
Zhang, Xinge, Hongjiang Wu, Eric S. H. Lau, et al.. (2024). Health impacts of new‐onset diabetes in women post‐gestational diabetes mellitus: Insights from Hong Kong's territory‐wide data. Journal of Diabetes Investigation. 15(6). 772–781.
4.
Cheung, Johnny T. K., Aimin Yang, Hongjiang Wu, et al.. (2024). Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability. Diabetes Obesity and Metabolism. 26(8). 3339–3351.
5.
Lim, Cadmon K.P., Ronald C.W., Eric S. H. Lau, et al.. (2024). Monogenic diabetes in a Chinese population with young‐onset diabetes: A 17‐year prospective follow‐up study in Hong Kong. Diabetes/Metabolism Research and Reviews. 40(5). e3823–e3823.
6.
Wu, Hongjiang, Aimin Yang, Eric S. H. Lau, et al.. (2024). 1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study. PLoS Medicine. 21(1). e1004327–e1004327.
7.
Chu, Natural, J Ling, Jie He, et al.. (2023). Higher dietary magnesium and potassium intake are associated with lower body fat in people with impaired glucose tolerance. Frontiers in Nutrition. 10. 1169705–1169705.
8.
Lau, Eric S. H., Aimin Yang, Hongjiang Wu, et al.. (2023). Temporal associations of diabetes‐related complications with health‐related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults—Joint Asia Diabetes Evaluation (JADE ) register (2007–2018). Journal of Diabetes. 16(6). e13503–e13503.
9.
Cheung, Johnny T. K., Aimin Yang, Hongjiang Wu, et al.. (2023). Early treatment with dipeptidyl‐peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score‐matched cohort study. Diabetes/Metabolism Research and Reviews. 40(1). e3711–e3711.
10.
Wu, Hongjiang, Aimin Yang, Eric S. H. Lau, et al.. (2023). Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: A territory-wide population-based cohort study of 1.5 million people in Hong Kong. PLoS Medicine. 20(8). e1004261–e1004261.
11.
Wu, Hongjiang, Eric S. H. Lau, Aimin Yang, et al.. (2023). Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 39(4). e3615–e3615.
12.
Wu, Hongjiang, Eric S. H. Lau, Aimin Yang, et al.. (2023). Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong. PLoS Medicine. 20(1). e1004173–e1004173.
13.
Zhang, Xinge, Hongjiang Wu, Baoqi Fan, et al.. (2022). Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study. PLoS Medicine. 19(7). e1004045–e1004045.
14.
Tomlinson, Brian, Elaine Chow, Paul Chan, & Christopher Wai Kei Lam. (2021). An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert Opinion on Drug Metabolism & Toxicology. 17(12). 1353–1361.
15.
Chow, Elaine, et al.. (2020). CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. SHILAP Revista de lepidopterología.
16.
Ke, Calvin, Thérèse A. Stukel, Baiju R. Shah, et al.. (2020). Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study. PLoS Medicine. 17(9). e1003316–e1003316.
17.
Cheng, Feifei, Andrea O. Y. Luk, Baoqi Fan, et al.. (2020). Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 43(9). 2257–2265.
18.
Weeks, Phillip, Elaine Chow, Athena L. Huang, et al.. (2019). Implementation of pharmacist‐managed anticoagulation in patients with continuous flow left ventricular assist devices. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(6). 623–627.
19.
Luk, Andrea O. Y., Eric S. H. Lau, Cadmon K.P. Lim, et al.. (2019). Diabetes-Related Complications and Mortality in Patients With Young-Onset Latent Autoimmune Diabetes: A 14-Year Analysis of the Prospective Hong Kong Diabetes Register. Diabetes Care. 42(6). 1042–1050.
20.
Wang, Jun, Janice Y. Tsoh, Adam Burke, et al.. (2014). A Pilot Study Using Traditional Chinese Medicine Providers to Promote Colorectal Cancer Screening in the Chinese American Community. The Journal of Alternative and Complementary Medicine. 20(5). A106–A107.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Josep Vehı́ Breakdown of academic impact, for papers by Robert F. Harrison Breakdown of academic impact, for papers by Lalo Magni Breakdown of academic impact, for papers by Ming Chen Breakdown of academic impact, for papers by Naoki Tanaka Breakdown of academic impact, for papers by Yung‐Hsiang Chen Breakdown of academic impact, for papers by Hubert Roth Breakdown of academic impact, for papers by John F. O’Brien Breakdown of academic impact, for papers by Jianmin Yang Breakdown of academic impact, for papers by Philippe Moulin